Almac Diagnostic Services Engager | In-Person Event

almac

Thursday, November 17 | Cambridge, UK | 6.00pm-8.30pm GMT

Please Note: This event is taking place in-person only, and online attendance will not be available.

Transforming Clinical Trial Assay Development in The Era of Precision Medicine

The Almac Diagnostic Services Engager is an exclusive event designed to bring together Biopharma Directors, Heads & VPs working in genomic precision medicine Biomarker Discovery, Assay Development & Validation, and Companion Diagnostics, to explore how to maximise the success of biomarker driven clinical trials globally.

Hear the latest insights and case studies on different approaches to clinical trial assay development, validation, and deployment in trials for both oncology and chronic disease indications, as well as exploring the latest thinking on IVDR Europe.

Join us for some short presentations and an insightful panel discussion followed by appetisers and drinks!

Expert Speakers Include:

Agenda:

6:00 pm Registration & Welcome Reception

6:30 pm Opening Remarks & Introduction

  • Michael Sloan Global Vice President, Commercial Operations, Almac Diagnostic Services

6:50 pm Challenges & Opportunities in the development of Companion Diagnostics in Clinical trials

  • Mark Fidock Vice President & Head of Diagnostic Development, AstraZeneca

Synopsis

  • Assay and regulatory considerations for the delivery of clinical diagnostic testing
  • Advances in diagnostic science to enable Precision Medicine studies of the future

6:50 pm Presentation Details TBC

Synopsis

Additional Pharma Speaker TBC

7:00 pm Clinical Trial Assay Development from a Lab Perspective: Challenges & Opportunities

  • Leeona Galligan Vice President of UK Operations, Almac Diagnostic Services

7:10 pm Panel Discussion

  • Mark Fidock Vice President & Head of Diagnostic Development, AstraZeneca
  • Leeona Galligan Vice President of UK Operations, Almac Diagnostic Services
  • Richard Kennedy Global Vice President of Biomarker Development & Medical Director, Almac Diagnostic Services
  • Stewart McWilliams Global Vice President of Quality & Regulatory Affairs, Almac Diagnostic Services

Synopsis

  • Explore different pharma approaches to clinical trials and assay development relating to oncology and chronic disease indications
  • Address the challenges & opportunities of design, validation and implementation of clinical trial assays from both Pharma and Diagnostic company perspectives
  • Discuss regulatory challenges around the latest thinking on IVDR Europe and impact in the industry
  • Explore how to maximise the success of biomarker driven clinical trials globally, including a focus on the importance of China

7:40 pm Networking & Drinks

Synopsis

This is an informal and exclusive networking opportunity for you to engage with biopharma leaders to discuss how to maximise the success of your biomarker-driven clinical trials!

8:30 pm End of Almac Diagnostic Services Engager

About Almac Diagnostic Services

almac

Always a move ahead in precision medicine

Your global partner for biomarker discovery, development & commercialisation.

Our global CLIA and CAP accredited laboratories cover UK, Europe, USA and APAC regions.

 

Our cores services:

Genomic Services

The flexibility of a range of genomics platform and chemistry options, alongside expert data sciences support & a full sample management service.

Clinical Trial Assays

Comprehensive CTA development, validation & delivery service for research and clinical use assays, alongside global clinical trial testing capabilities.

Companion Diagnostics

A collaborative end to end CDx development, manufacture & commercialisation service with the organisational and logistical resources necessary to launch tests in major markets.

 

Make the winning move today

www.almacgroup.com/diagnostics